These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34416045)

  • 1. Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performance.
    Cantet G; Berges A; O'Sullivan R; Cohen-Rabbie S; Dota C; Dubois V; Benoist GE; Tomkinson H; Rekić D; Parkinson J; Schalkwijk S
    Br J Clin Pharmacol; 2022 Mar; 88(3):1010-1019. PubMed ID: 34416045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis.
    Freise KJ; Dunbar M; Jones AK; Hoffman D; Enschede SL; Wong S; Salem AH
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):847-53. PubMed ID: 27586967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-QTc analysis for single arm studies.
    Orihashi Y; Ohwada S; Kumagai Y
    J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):203-211. PubMed ID: 33512637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia.
    Nagele P; Pal S; Brown F; Blood J; Miller JP; Johnston J
    Anesthesiology; 2012 Aug; 117(2):321-8. PubMed ID: 22692379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.
    Kannankeril PJ; Norris KJ; Carter S; Roden DM
    Heart Rhythm; 2011 Oct; 8(10):1530-4. PubMed ID: 21420510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.
    Darpo B; Karnad DR; Badilini F; Florian J; Garnett CE; Kothari S; Panicker GK; Sarapa N
    Br J Clin Pharmacol; 2014 Mar; 77(3):522-31. PubMed ID: 23819796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects.
    Darpö B; Sager P; MacConell L; Cirincione B; Mitchell M; Han J; Huang W; Malloy J; Schulteis C; Shen L; Porter L
    Br J Clin Pharmacol; 2013 Apr; 75(4):979-89. PubMed ID: 22882281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
    Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meperidine-induced QTc-interval prolongation: prevalence, risk factors, and correlation to plasma drug and metabolite concentrations
.
    Keller GA; Villa Etchegoyen MC; Fernández N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):275-285. PubMed ID: 27509828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
    Khalilieh SG; Yee KL; Fan L; Liu R; Heber W; Dunzo E; Triantafyllou I; Hussaini A; Iwamoto M
    Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of the effect of gadopiclenol, a new gadolinium-based contrast agent, on the QTc interval in healthy subjects.
    Funck-Brentano C; Felices M; Le Fur N; Dubourdieu C; Desché P; Vanhoutte F; Voiriot P
    Br J Clin Pharmacol; 2020 Nov; 86(11):2174-2181. PubMed ID: 32302009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies.
    Mendzelevski B; Ferber G; Janku F; Li BT; Sullivan RJ; Welsch D; Chi W; Jackson J; Weng O; Sager PT
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1129-1141. PubMed ID: 29603015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers.
    Wu J; Cao G; Wu H; Chen Y; Guo B; Wu X; Yu J; Ni K; Qian J; Wang L; Wu J; Wang Y; Yuan H; Zhang J; Xi Y
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferasirox does not induce QT/QTc-prolongation in healthy subjects.
    Sechaud R; Dumortier T; Balez S
    Int J Clin Pharmacol Ther; 2009 May; 47(5):321-7. PubMed ID: 19473594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based evaluation of drug-induced QTc prolongation for compounds in early development.
    Dubois VF; Yu H; Danhof M; Della Pasqua O;
    Br J Clin Pharmacol; 2015 Jan; 79(1):148-61. PubMed ID: 25099645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of moxifloxacin in canine and non-human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration-QTc analysis.
    Chui RW; Baublits J; Chandra FA; Jones ZW; Engwall MJ; Vargas HM
    Clin Transl Sci; 2021 Nov; 14(6):2379-2390. PubMed ID: 34173339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.
    Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E
    Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.